Stefanie L Bolte, | |
10707 Pacific St, Suite 101, Omaha, NE 68114-4762 | |
(402) 397-7989 | |
(402) 393-7554 |
Full Name | Stefanie L Bolte |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 10707 Pacific St, Omaha, Nebraska |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104877018 | NPI | - | NPPES |
098396 | Other | NE | MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | 44887 (Wisconsin) | Secondary |
208800000X | Urology | 23778 (Nebraska) | Primary |
208800000X | Urology | 36776 (Iowa) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Stefanie L Bolte, Po Box 8577, Omaha, NE 68108-0577 Ph: (402) 397-7989 | Stefanie L Bolte, 10707 Pacific St, Suite 101, Omaha, NE 68114-4762 Ph: (402) 397-7989 |
News Archive
Screening people for Clostridium difficile before they are admitted to hospital may be one way to help control rising rates of infection, says a doctor in the British Medical Journal.
MicroStockProfit.com announces an investment report featuring Cell Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
In the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Eric Porterfield, director of global health communications at the United Nations Foundation, interviews Jeffrey Bates, a polio communications for development (C4D) officer, about India's efforts to eradicate polio.
In the first systematic large-scale evaluation of the UK National Early Warning Risk Score (NEWS) 2 as a scoring system for predicting severe COVID-19 outcomes in patients, researchers at King's College London have found poor-to-moderate accuracy for identifying patients at risk of being transferred to intensive care units (ICUs) or dying after 14 days of hospitalization.
Labopharm Inc. today announced its wholly owned subsidiary, Labopharm Europe Limited, has completed a distribution and supply agreement with Merck Sharp & Dohme Limited (MSD), a United Kingdom (U.K.) subsidiary of Merck & Co., Inc., under which MSD will distribute and market Tradorec XL(R) (once-daily tramadol based on Labopharm's proprietary Contramid(R) technology).
› Verified 1 days ago
Dr. Patrick B Leu, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 111 S 90th St, Omaha, NE 68114 Phone: 402-397-9800 Fax: 402-397-7591 | |
Dr. Harvey A Konigsberg, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 111 S 90th St, Omaha, NE 68114 Phone: 402-397-9800 Fax: 402-397-7591 | |
Dr. Jennifer Dwyer, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 984110 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-4284 | |
Michael P Feloney, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 7710 Mercy Rd Ste 1000, Omaha, NE 68124 Phone: 402-717-2500 Fax: 402-717-2525 | |
Dr. Jon J Morton, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 111 S 90th St, Omaha, NE 68114 Phone: 402-397-9800 Fax: 402-397-7591 | |
Dr. Charles Brent Wakefield Ii, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 10707 Pacific St, Suite 101, Omaha, NE 68114 Phone: 402-397-7989 Fax: 402-393-7554 |